William Raestetter

Title: The Innovations of William Raestetter

Introduction

William Raestetter is a notable inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of medical technology, particularly in the area of hematologic toxicity related to radioimmunotherapy. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.

Latest Patents

Raestetter's latest patents focus on clinical parameters for determining hematologic toxicity prior to radioimmunotherapy. These patents report new clinical parameters that may serve as predictors of the hematological toxicity associated with therapeutic radiolabeled antibodies. This is particularly relevant for antibodies that target lymphoma cells, which have a tendency to localize to the bone marrow. His innovative approach aims to enhance the safety and efficacy of treatments involving these antibodies.

Career Highlights

Throughout his career, Raestetter has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Idec Pharmaceuticals Corporation and Biogen Idec, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex medical challenges.

Collaborations

Raestetter has collaborated with various professionals in his field, including Christine A White. These partnerships have likely enriched his research and development efforts, leading to advancements in medical technology.

Conclusion

William Raestetter's contributions to the field of medical technology through his patents and collaborations highlight his commitment to improving patient care. His work in determining hematologic toxicity prior to radioimmunotherapy is a testament to his innovative spirit and dedication to advancing medical science.